Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) Short Interest Down 11.2% in June

Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) was the target of a significant drop in short interest in June. As of June 15th, there was short interest totalling 11,470,000 shares, a drop of 11.2% from the May 31st total of 12,910,000 shares. Currently, 4.3% of the shares of the stock are sold short. Based on an average daily trading volume, of 2,600,000 shares, the days-to-cover ratio is currently 4.4 days.

Asensus Surgical Stock Performance

Shares of NYSEAMERICAN:ASXC opened at $0.33 on Wednesday. Asensus Surgical has a one year low of $0.20 and a one year high of $0.65.

Asensus Surgical (NYSEAMERICAN:ASXC) last issued its quarterly earnings results on Tuesday, May 14th. The company reported ($0.07) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.02). Asensus Surgical had a negative net margin of 902.25% and a negative return on equity of 184.10%. The firm had revenue of $1.12 million during the quarter, compared to the consensus estimate of $1.10 million. On average, equities research analysts expect that Asensus Surgical will post -0.24 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, HC Wainwright restated a “neutral” rating and issued a $0.35 price target on shares of Asensus Surgical in a research report on Thursday, May 16th.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Asensus Surgical stock. Virtu Financial LLC grew its holdings in shares of Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) by 834.4% in the first quarter, according to its most recent filing with the SEC. The firm owned 249,019 shares of the company’s stock after acquiring an additional 222,368 shares during the quarter. Virtu Financial LLC owned about 0.09% of Asensus Surgical worth $57,000 as of its most recent SEC filing. 9.35% of the stock is owned by hedge funds and other institutional investors.

Asensus Surgical Company Profile

Asensus Surgical, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients.